SRSF2 and myelodysplastic syndrome: Patients with this mutation showed an obvious trend towards inferior overall survival according to univariate analysis in the whole patient cohort with follow-up data, while multivariate analysis revealed that SRSF2 mutation was an independent adverse prognostic factor in MDS.